Cargando…

Genome-scale CRISPR screening for potential targets of ginsenoside compound K

Ginsenosides exhibit a large variety of biological activities in maintaining physical health; however, the molecule underpinnings underlining these biological activities remain to be defined. Here, we took a cellular condition that compound K (CK) induces autophagic cell death in HeLa cells, and set...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yuanyuan, Liu, Xiaojian, Li, Shuang, Chen, Yanhao, Zhao, Yongxu, Wei, Yuda, Qiu, Yan, Liu, Yan, Zhou, Zhihua, Han, Jun, Wu, Guohao, Ding, Qiurong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971025/ https://www.ncbi.nlm.nih.gov/pubmed/31959745 http://dx.doi.org/10.1038/s41419-020-2234-5

Ejemplares similares

Glyburide Regulates UCP1 Expression in Adipocytes Independent of K(ATP) Channel Blockade
por: Qiu, Yan, et al.
Publicado: (2020)

Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue
por: Qiu, Yan, et al.
Publicado: (2018)

Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells
por: Li, Shuang, et al.
Publicado: (2018)

CRISPR/Cas9 with single guide RNA expression driven by small tRNA promoters showed reduced editing efficiency compared to a U6 promoter
por: Wei, Yuda, et al.
Publicado: (2017)

Acute liver steatosis translationally controls the epigenetic regulator MIER1 to promote liver regeneration in a study with male mice
por: Chen, Yanhao, et al.
Publicado: (2023)

Optimized protocols for efficient gene editing in mouse hepatocytes in vivo using CRISPR-Cas9 technology
por: Chen, Yanhao, et al.
Publicado: (2021)

Systematic optimization of the yeast cell factory for sustainable and high efficiency production of bioactive ginsenoside compound K
por: Wang, Pingping, et al.
Publicado: (2021)

A narrative review of the pharmacology of ginsenoside compound K
por: Liu, Tao, et al.
Publicado: (2022)

Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology
por: Qiu, Yan, et al.
Publicado: (2021)

Ginsenoside Compound K Assisted G-Quadruplex Folding and Regulated G-Quadruplex-Containing Transcription
por: Zhang, Yan, et al.
Publicado: (2021)

Functional Mechanism of Ginsenoside Compound K on Tumor Growth and Metastasis
por: Liu, Jinlong, et al.
Publicado: (2022)

Identification of a rhodanine derivative BML-260 as a potent stimulator of UCP1 expression
por: Feng, Zhuanghui, et al.
Publicado: (2019)

Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
por: Chen, Yan, et al.
Publicado: (2013)

Polymorphic Characterization, Pharmacokinetics, and Anti-Inflammatory Activity of Ginsenoside Compound K Polymorphs
por: Kuang, Yun-Yan, et al.
Publicado: (2021)

Highly Selective Bioconversion of Ginsenoside Rb1 to Compound K by the Mycelium of Cordyceps sinensis under Optimized Conditions
por: Wang, Wei-Nan, et al.
Publicado: (2015)

Adhesive ginsenoside compound K patches for cartilage tissue regeneration
por: Yang, Jun-Ho, et al.
Publicado: (2023)

Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis
por: Ding, Lingli, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Ginsenoside Compound K Derivatives as a Novel Class of LXRα Activator
por: Huang, Yan, et al.
Publicado: (2017)

Biotransformation of Ginsenoside Rb(1) to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F(2), and Compound K by Leuconostoc mesenteroides DC102
por: Quan, Lin-Hu, et al.
Publicado: (2011)

Production of bioactive ginsenoside Rg3(S) and compound K using recombinant Lactococcus lactis
por: Li, Ling, et al.
Publicado: (2018)

Corrigendum: Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis
por: Ding, Lingli, et al.
Publicado: (2022)

Anticancer properties and pharmaceutical applications of ginsenoside compound K: A review
por: Zhou, Li, et al.
Publicado: (2021)

Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids
por: Wu, Xiaoshan, et al.
Publicado: (2023)

Biotransformation of High Concentrations of Ginsenoside Substrate into Compound K by β-glycosidase from Sulfolobus solfataricus
por: Wang, Pan, et al.
Publicado: (2023)

Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy
por: Jin, Xin, et al.
Publicado: (2018)

An Insight into Ginsenoside Metabolite Compound K as a Potential Tool for Skin Disorder
por: Kim, En Hyung, et al.
Publicado: (2018)

The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells
por: Lee, Sanghun, et al.
Publicado: (2017)

Ginsenoside Compound K: Insights into Recent Studies on Pharmacokinetics and Health-Promoting Activities
por: Sharma, Anshul, et al.
Publicado: (2020)

Effect of ginsenoside compound K on alleviating colitis via modulating gut microbiota
por: Wang, Li, et al.
Publicado: (2022)

Ginsenoside compound K alleviates osteoarthritis by inhibiting NLRP3‑mediated pyroptosis
por: Li, Yuguo, et al.
Publicado: (2023)

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress
por: Ding, Lingli, et al.
Publicado: (2023)

Targeting NECTIN-1 Based on CRISPR/Cas9 System Attenuated the Herpes Simplex Virus Infection in Human Corneal Epithelial Cells In Vitro
por: Li, Yue, et al.
Publicado: (2022)

Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng
por: Xiao, Jian, et al.
Publicado: (2016)

Ginsenoside compound K reduces neuronal damage and improves neuronal synaptic dysfunction by targeting Aβ
por: Li, Na, et al.
Publicado: (2023)

Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats
por: Chen, Xu-Jia, et al.
Publicado: (2017)

The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway
por: Zeng, Xiangchang, et al.
Publicado: (2018)

Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2
por: Wang, Yu-Shi, et al.
Publicado: (2019)

Effects of ginsenoside compound K on colitis-associated colorectal cancer and gut microbiota profiles in mice
por: Shao, Li, et al.
Publicado: (2022)

Biochemical Targets and Molecular Mechanism of Ginsenoside Compound K in Treating Osteoporosis Based on Network Pharmacology
por: Zhang, Sen, et al.
Publicado: (2022)

Ginsenoside compound K inhibits the proliferation, migration and invasion of Eca109 cell via VEGF-A/Pi3k/Akt pathway
por: Huang, Jianhou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ctcoo4jjpurerkgkgqo5pd68l